Clinical trial Recruiting at 1 site Observational Men only

Smart wearable for monitoring bladder function in men with BPH

Official title: An Intelligent Wearable Device Based on Electrical Impedance Tomography for Dynamic and Accurate Monitoring of Voiding Function in Patients With Benign Prostatic Hyperplasia

Run by Peking University Third Hospital · NCT07357012 · Data updated 2026-11-12

A non-invasive wearable device is tested to see if it can measure bladder function as accurately as the standard uroflowmetry test in men with BPH.

Quick facts

Study typeObservational
SexMen only
Enrollment40 (estimated)
SponsorPeking University Third Hospital
Academic / other
Drugs / interventionsradiation
Locations2 sites (Beijing, HaiDian and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedFebruary 1, 2026
Study endsAugust 1, 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07357012 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Men with BPH who need urodynamic testing to evaluate LUTS prior to invasive treatment and can provide informed consent.

Probably not a fit

Patients who do not experience improved accuracy, comfort, or convenience from wearable monitoring compared with standard testing.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study tests a lower-abdominal wearable device that uses Electrical Impedance Tomography to monitor bladder function in men with benign prostatic hyperplasia. Participants will wear the device while undergoing traditional uroflowmetry to compare measurements such as maximum and average urine flow rate and voided volume. The goal is to determine agreement between the wearable’s data and the standard test, with additional exploration of dynamic bladder volume tracking and AI-based analysis. The study is conducted at a single center and aims to assess feasibility, accuracy, and potential for at-home monitoring. Eligibility focuses on patients requiring urodynamic evaluation prior to invasive treatment, with several safety-related exclusions to reduce risk.

Why it matters

Potential benefit: If successful, this device could offer a comfortable, non-invasive way to monitor bladder function over time, potentially enabling home or continuous monitoring for BPH patients.

How similar studies have gone: Previous work in similar non-invasive wearable EIT approaches has shown promise but remains relatively early-stage and requires further validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients with BPH who need urodynamic tests to further evaluate the underlying pathophysiology of LUTS prior to invasive treatment.

Patients who understand and agree with the written informed consent, and voluntary to participate in the study.

Exclusion Criteria:

Patients with catheter-dependent urinary retention. Patients who cannot void \> 150ml. Patients with uncontrolled acute urinary tract infections. Patients who suffer from severe mental illness or other diseases that may affect judgment or cooperation during the study.

Patients with implanted cardiac pacemaker or other electronic implants that may potentially be interfered by the EIT device.

Patients with other conditions who are deemed unsuitable for participation by the investigator.

Where it's running

  • Peking University Third Hospital
    Beijing, HaiDian, China
    Recruiting
  • Peking University Third Hospital
    Beijing, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.